Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-05-18 00:00:00 ET · period of report 2022-05-16 · accession 0001567619-22-011218 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-18 | 2022-05-16 | BMRN | Burkhart Erin | CAO, GVP | A - Grant | $0.00 | +11.1K | 11.1K | New | $0 |
| D | 2022-05-18 | 2022-05-16 | BMRN | Burkhart Erin | CAO, GVP | A - Grant | $0.00 | +17.5K | 17.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-16 | A | A | 11,130 | $0.00 | 11,130 | D | — | — | (F1) Restricted stock units granted on May 16, 2022. Price not applicable. |
| 2 | Derivative | Stock Option (Right to buy Common Stock) | 2022-05-16 | A | A | 17,490 | $0.00 | 17,490 | D | $77.32 · 2023-05-16 to 2032-05-15 | 17,490 Common Stock | (F2) Option grant vests 12/48th on May 16, 2023 and 1/48th on the 16th day of each month thereafter. |